{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T02:09:42Z","timestamp":1773022182152,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR220088"],"award-info":[{"award-number":["RR220088"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.molmed.2023.05.011","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T08:08:10Z","timestamp":1686643690000},"page":"584-585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Fatty acid binding proteins in multiple myeloma"],"prefix":"10.1016","volume":"29","author":[{"given":"Camila","family":"Diedrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Maksimos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6371-2780","authenticated-orcid":false,"given":"Abdel Kareem","family":"Azab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2023.05.011_bb0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1043-2760(00)00257-5","article-title":"The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function","volume":"15","author":"Hertzel","year":"2000","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2023.05.011_bb0010","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2023.05.011_bb0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0163-7827(96)00006-9","article-title":"Cellular fatty acid-binding proteins: their function and physiological significance","volume":"3","author":"Glatz","year":"1996","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.molmed.2023.05.011_bb0020","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/ijc.28903","article-title":"Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression","volume":"135","author":"Uehara","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molmed.2023.05.011_bb0025","first-page":"1221","article-title":"FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K\/AKT signaling pathway","volume":"54","author":"Lv","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.molmed.2023.05.011_bb0030","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1038\/leu.2017.138","article-title":"Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study","volume":"31","author":"Kumar","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.molmed.2023.05.011_bb0035","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81184","article-title":"Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling","volume":"12","author":"Farrell","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.molmed.2023.05.011_bb0040","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1182\/blood-2008-10-186668","article-title":"CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy","volume":"113","author":"Azab","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2023.05.011_bb0045","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1182\/blood-2011-07-368050","article-title":"P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment","volume":"119","author":"Azab","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2023.05.011_bb0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bone.2018.03.011","article-title":"Bone marrow adiposity and multiple myeloma","volume":"118","author":"Morris","year":"2019","journal-title":"Bone"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491423001016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491423001016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:27:12Z","timestamp":1761463632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491423001016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1471491423001016"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2023.05.011","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fatty acid binding proteins in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2023.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}